Results 161 to 170 of about 188,190 (277)
Background: Canine otitis externa (COE) is one of the most frequently recorded disorders in veterinary practices, making it an important focus for antibiotic stewardship. Hypothesis/Objectives: To investigate and compare treatment regimens for acute COE in Finland, Norway and Sweden, with a focus on antibiotic use.
Kaisa Saarinen +4 more
wiley +1 more source
Allergen Immunotherapy for the Treatment of Eosinophilic Esophagitis. An EAACI Task Force Systematic Review. [PDF]
Votto M +17 more
europepmc +1 more source
Background: Otitis externa (OE) represents a common clinical problem in dogs. Allergic dogs exhibit reduced diversity of the otic microbiota, and inflammation‐induced changes in the ear canal microenvironment result in a further decline in microbial biodiversity.
Isaac Carrasco +4 more
wiley +1 more source
Allergen Immunotherapy and Possible Clinical Remission: Toward a Disease-Modifying Paradigm in Allergic Disorders. [PDF]
Furci F +8 more
europepmc +1 more source
Adverse reactions and tolerability of high-dose sublingual allergen immunotherapy
Angel Moral,1 Victoria Moreno,2 Francisco Girón,3 David El-Qutob,4 José D Moure,5 Manuel Alcántara,6 Antonia Padial,7 Alberto G Oehling,8 Carmen Millán,9 Fernando de la Torre10 1Allergy Service, Hospital Virgen del Valle ...
Moral A +9 more
core
ABSTRACT Background Chronic rhinosinusitis (CRS) and allergic rhinitis (AR) are two highly prevalent airway diseases in the United States. While the coexistence of CRS and asthma is well recognized, less is known about the development of new‐onset asthma in CRS, particularly in the context of comorbid AR. This study assessed the impact of CRS and AR on
Austin J. Lee, Mohamad R. Chaaban
wiley +1 more source
Sublingual allergen immunotherapy in immunosuppressed rheumatoid arthritis patients: Safety and clinical outcomes. [PDF]
Kobayashi Y +7 more
europepmc +1 more source
Patient preference in allergen immunotherapy - Understanding the patient's view. [PDF]
Becker S +18 more
europepmc +1 more source

